Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept Clinical Trial of Gene Therapy GVB-2001 Delivered Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

NCT06921317 is registered in ClinicalTrials.gov with IVIEW Therapeutics Inc. as lead sponsor.

NCT NCT06921317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06921317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept Clinical Trial of Gene Therapy GVB-2001 Delivered Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
Lead sponsor
IVIEW Therapeutics Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
November 19, 2025
Completion date
February 28, 2028
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary open-angle glaucoma (poag)